Tofacitinib-13C3 is a carbon-13 labeled variant of Tofacitinib. Tofacitinib acts as a JAK3/2/1 inhibitor, exhibiting IC50 values of 1 nM, 20 nM, and 112 nM, respectively.
Target:
JAK|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
